BioPharm International, February 2012 Issue (PDF)
Investing in BioPharma Outsourcing
Trends and Challenges in Biologics Outsourcing: A Q&A with Stephen Taylor
Stephen Taylor PhD, vice-president and commercial director at Fujifilm Diosynth Biotechnologies, addresses some of the challenges facing biologics outsourcing.
Biomanufacturing Outsourcing Outlook
Industry optimism is on the rise for 2012.
Preparing For the New China
China's healthcare reforms generate uncertainty for its domestic pharmaceutical market.
What the 2011 Census of India Reveals for Pharma
The census reveals the state of the population of India's health and the potential for growth in the healthcare market.
Saving the Next Generation of Regulatory Scientists
New educational programs are key to the industry's future and to safe, available drugs.
A Risk-Based Approach to Transferring a Mature Biopharmaceutical Process
Strategies for transfer of the manufacturing process.
PQRI Case Study: Facility Biocontainment and Inactivation
A Risk-Management Case Study.
Assessing the Risk of Leachables from Single-Use Systems
This article is the second in a two-part series on extractables and leachables.
Sustainable Investment
Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference.
Understanding Gamma Sterilization
This article outlines methods, validation standards, and documentation of sterilization of single-use products using gamma irradiation.
A 25-Year Retrospective on Mammalian Cell Culture
This month, we revisit "Industrial-Scale Mammalian Cell Culture, Part I: Bioreactor Design Considerations."
The Drive for Best Practice in Biopharmaceutical Manufacturing
Introducing a new way to think about sharing information in a patent-driven industry.
FDA and Justice Department Address Drug Quality Concerns
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
The Challenges of Emerging Markets
The difficulties of doing business in China are offset by its adoption of more stringent GMP standards.
